RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 98 filers reported holding RELMADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $121,107 | -24.8% | 40,369 | -38.4% | 0.02% | -42.3% |
| Q2 2023 | $161,109 | +8.9% | 65,491 | 0.0% | 0.03% | -23.5% |
| Q1 2023 | $148,010 | -35.2% | 65,491 | 0.0% | 0.03% | -38.2% |
| Q4 2022 | $228,563 | -99.6% | 65,491 | -95.8% | 0.06% | -99.5% |
| Q3 2022 | $57,404,000 | +419.0% | 1,550,600 | +166.3% | 11.44% | +467.1% |
| Q2 2022 | $11,060,000 | +1781.0% | 582,300 | +2571.0% | 2.02% | +2519.5% |
| Q1 2022 | $588,000 | +25.9% | 21,801 | +5.1% | 0.08% | +10.0% |
| Q4 2021 | $467,000 | -14.2% | 20,743 | 0.0% | 0.07% | +84.2% |
| Q3 2021 | $544,000 | -96.6% | 20,743 | -95.9% | 0.04% | -97.1% |
| Q2 2021 | $16,120,000 | -6.1% | 503,607 | +3.2% | 1.30% | +125.4% |
| Q1 2021 | $17,176,000 | +812.6% | 487,807 | +784.2% | 0.58% | +307.0% |
| Q1 2020 | $1,882,000 | – | 55,172 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |